{"text": ["Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4 | Blood Cancer Journal"], "created_at": "Fri, 02 Oct 2015 07:00:00 GMT"}
